Cervical cancer is a tumour of the cervix, the part of the uterus that adjoins the vagina in the female reproductive tract. Certain types of human papillomavirus (HPV) are implicated in more than 90% of these cancers, although the great majority of HPV infections of the cervix are not associated with cancer. HPV is transmitted by vaginal sex, infecting cervical epithelial cells. In a minority of cases, infection persists for years, and pre-cancerous changes called cervical intraepithelial neoplasia can develop, which sometimes progress to cancer. Squamous cell carcinomas are the most common. HPV infection is considered essential for nearly all forms of cervical cancer to develop, but other risk factors are also involved, including smoking, HIV infection and other forms of immune suppression, and long-term use of oral contraceptives.

Cervical cancer is the fourth most common cancer in women worldwide. It can be detected by screening; screening every 3–5 years, with appropriate follow-up, can reduce cancer incidence by up to 80%. HPV vaccines protect against high-risk virus strains, and can prevent up to 90% of cervical cancers. Where screening and vaccination are not available, cervical cancer has substantial mortality; worldwide, an estimated 569,000 cases and 311,000 deaths occurred in 2018, with around 85% of cases being in developing countries.

Biosafety level 3 equipment is used for research with viruses such as influenza that can cause serious disease but for which treatment is available. The biosafety cabinet uses HEPA filters to filter viruses out of the air. This researcher is examining reconstructed 1918 pandemic influenza virus, or "Spanish flu".

Credit: CDC (2005)

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Virus classification is the process of naming viruses and placing them into a taxonomic system. They are mainly classified by phenotypic characteristics, such as morphology, nucleic acid type, mode of replication, host organisms and the type of disease they cause.

Two schemes are in common use. The International Committee on Taxonomy of Viruses (ICTV), established in the early 1970s, classifies viruses into taxa (groups) similar to the biological classification used for cellular organisms, which reflect viruses believed to have a common ancestor. As of 2019, 9 kingdoms, 16 phyla, 36 classes, 55 orders, 168 families, 1,421 genera and 6,589 species of viruses have been defined. Since 2018, viruses have also been classified into higher-level taxa called realms. Four realms are defined, as of 2020, encompassing almost all RNA viruses; some DNA viruses have yet to be assigned a realm.

The older Baltimore classification (pictured), proposed in 1971 by David Baltimore, places viruses into seven groups (I–VII) based on their nucleic acid type, number of strands and sense, as well as the method the virus uses to generate mRNA. There is some concordance between Baltimore groups and the higher levels of the ICTV scheme.

The 1993 hantavirus outbreak in the Four Corners region of southwest USA was of a novel hantavirus, subsequently named Sin Nombre virus. It caused the previously unrecognised hantavirus pulmonary syndrome – the first time that a hantavirus had been associated with respiratory symptoms. Mild flu-like symptoms were followed by the sudden onset of pulmonary oedema, which was fatal in half of those affected. A total of 24 cases were reported in April–May 1993, with many of those affected being from the Navajo Nation territory. Hantavirus infection of humans generally occurs by inhaling aerosolised urine and faeces of rodents, in this case the deer mouse (Peromyscus; pictured).

Previously documented hantavirus disease had been confined to Asia and Europe, and these were the first human cases to be recognised in the USA. Subsequent investigation revealed undiagnosed cases dating back to 1959, and Navajo people recalled similar outbreaks in 1918, 1933 and 1934.